Special Issue "Cancer Genomics: Interpreting the Changing Landscape in Cancer Diagnosis and Treatment"
Deadline for manuscript submissions: 31 October 2021.
Interests: alternative Splicing; RNA metabolism; cancer genomics; RNA binding proteins; Ewing sarcoma
Special Issues and Collections in MDPI journals
The expanding knowledge and comprehension of human genetics are transforming the path and direction of research and medical approaches to cancer diagnosis and treatment.
Recent high-throughput sequencing technologies are gradually reshaping our understanding of cancer origin and complexity, providing more reliable information on tumor progression, metastases, and survival. Genome sequencing is now yielding insightful information about genetic mutations that trigger or contribute to cancer development and how cancer evolves in response to treatments. In this way, cancer-genome profiling is now providing an important tool for the assessment of molecular cancer subtypes and the most appropriate therapeutic options for patients in routine clinical practice. Deciphering the temporal series of events leading to cancer is essential for a comprehensive understanding of tumorigenesis, and for identifying the earliest markers in tumor development, ensuring faster diagnosis and treatment, as well as improving the capability to predict disease progression.
This Special Issue will cover key cancer genetics concepts and cutting-edge clinical applications.
Prof. Dr. Maria Paola Paronetto
Dr. Claudia Ghigna
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Genomic profiling
- Cancer trademarks
- Mutational signatures
- Cancer therapeutics
- Post-transcriptional alterations in human cancers